This is a critical factor in managing or preventing type 2 diabetes
Stewart AG, Marsh F, Waterhouse JC, Howard P
All flow cytometry data were analyzed using FlowJo software (v10.10.0)
"We think that the full panoply of conditions that this set of drugs can cause are not fully warned of," Jonathan Orent, co-lead counsel for plaintiffs in the MDL, told USA Today
When you're evaluating a creatine product, the ingredient list should be short
Risk factors that may prompt additional consideration include: Active gastrointestinal symptoms (nausea, vomiting, abdominal pain) Recent dose increases or being in the dose-escalation phase Higher doses of semaglutide Known gastroparesis or other conditions affecting gastric emptying Obesity with GERD or hiatal hernia Based on the 2024 multi-society guidance, most patients can continue GLP-1 receptor agonists before elective procedures with appropriate risk assessment and mitigation strategies, rather than automatic postponement